H M Lokhorst

Natural history of relapsed myeloma, refractory to immunomodulatory drugs and proteasome inhibitors: a multicenter IMWG study

Shaji Kumar, Meletios Α. Dimopoulos, Efstathios Kastritis et al. · Leukemia · 2017 · 354 citations · Full text

Medicine, Immunology, Oncology +17

Modulation of multidrug-resistant multiple myeloma by cyclosporin

Pieter Sonneveld, Bob Löwenberg, B G M Durie et al. · The Lancet · 1992 · 315 citations

Medicine, Oncology, Pharmacology +12

A gene expression signature for high-risk multiple myeloma

Rowan Kuiper, Annemiek Broyl, Yvonne de Knegt et al. · Leukemia · 2012 · 303 citations

Medicine, Molecular Biology, Oncology +14

Donor Lymphocyte Infusions for Relapsed Multiple Myeloma After Allogeneic Stem-Cell Transplantation: Predictive Factors for Response and Long-Term Outcome

H M Lokhorst, A Schattenberg, Jan J. Cornelissen et al. · Journal of Clinical Oncology · 2000 · 287 citations

Medicine, Hematology, Immunology +16

Allogeneic transfusion and infection: economic and clinical implications.

P Sonneveld, H M Lokhorst, Paula J.M. Vossebeld · PubMed · 1997 · 273 citations

Medicine, Oncology, Pharmacology +14